Prevalence of symptoms associated with Polycystic Ovary Syndrome
Abstract
Polycystic Ovary Syndrome (PCOS) is one of the most frequent endocrinopathies in women of reproductive age and reflects interactions between genetic, metabolic and environmental factors. This research aimed to identify the prevalence of symptoms associated with PCOS in women with the syndrome and to compare them to women without the disease, through an online questionnaire. 2458 women were evaluated, 1229 in the PCOS group, aged between 15 and 45 years, matched for age with 1229 women without PCOS in the control group. The mean age was 28.05 (5.98) years, with no differences between groups (p=0.999). Women with PCOS had higher weight, BMI and a higher prevalence of obesity and overweight when compared to the control group (p<0.001). As for menstrual and reproductive parameters, women with PCOS had a higher prevalence of irregular menstrual cycle (55.7%; 25.2%, p<0.001), greater difficulty in becoming pregnant (p<0.001) and amenorrhea for more than two months (p<0.001) when compared to the control group. The prevalence, in percentage values, of obesity, anxiety and depression was higher in women with PCOS. Women in the PCOS group had greater weight gain in the last six months (p=0.031) and reported more difficulty in losing weight, acne, hirsutism and hair loss when compared with women without PCOS (p<0.001). This study allowed us to conclude that women with PCOS present more changes in menstrual, reproductive and clinical parameters when compared to the control group, highlighting the importance of multidisciplinary strategies to alleviate these symptoms and ensure a better quality of life for these women.
References
-Almeida, Y.F.; Viana, L.M.; Caixeta, L.V.V.; Vieira, Y.A.; Alves, B.L.R.; Cardoso, A.S. Qualidade de vida em mulheres com Síndrome do Ovário Policístico. Revista Eletrônica Acervo Saúde. Vol. 35. 2019. p. e1464.
-Azziz, R. Polycystic ovary syndrome. Obstetrics and Gynecology. Vol. 132. Num. 2. 2018. p. 321-336.
-Berni, T.R.; Morgan, C.L.; Berni, E.R.; Rees, D.A. Polycystic Ovary Syndrome Is Associated with Adverse Mental Health and Neurodevelopmental Outcomes. The Journal of Clinical Endocrinology and Metabolism. Vol. 103. Num. 6. 2018. p. 2116-2125.
-Costa, L.O.B.F.; Viana, A.O.R.; Oliveira, M. Prevalence of the metabolic syndrome in women with polycystic ovary syndrome. Medicine: Gynecology and obstetrics. Vol. 29. Num. 1. 2007. p. 10-17.
-Freitas, L.A.R.; Santos, J.G.; Guimaraes, M.T.A.; Souza, J.H.K. Uso de metformina em mulheres obesas com síndrome do ovário policístico. Revista de Ciências Médicas. Vol. 25. Num. 2. 2016. p. 87-97.
-Fruzzetti, F.; Gujadoni, L.; Virdis, A.; Negri, F.; Perini, D.; Bucci, F.; Giannerelli, C.; Gadducci, A.; Taddei, S. Adolescents with classical polycystic ovary syndrome have alterations in the surrogate markers of cardiovascular disease but not in the benefits of metformin. Journal of Pediatric and Adolescent Gynecology. Vol. 29. Num. 5. 2016. p. 489-495.
-Gonçalves, M.M.; Fonseca, H.P.; Fukunaga, E.T.; Aldrighi, J.M. Interferência dos Hábitos Alimentares Nutricionais no Perfil Metabólico de Mulheres com Síndrome dos Ovários Policísticos. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo. Vol. 63. Num. 1. 2018. p. 6-11.
-Mota, C.R.F.C. Influência da Resistência à Insulina sobre Índices Lipídicos e Probabilidade de Evento Coronariano. Dissertação de Mestrado. Universidade Federal de Pernambuco. Recife. 2011.
-Moura, H.H.G.; Costa, D.L.M.; Bagatin, E.; Sodre, C.T.; Azulay, M.M. Síndrome do ovário policístico: abordagem dermatológica. Anais Brasileiros de Dermatologia. Vol. 86. Num.1. 2011. p. 111-119.
-Neves, E.M. Síndrome dos Ovários Policísticos: Correlação dos fenótipos com as Alterações Metabólicas. Dissertação de Mestrado. Faculdade de Medicina da USP. São Paulo. 2013.
-Ortiz-Flores, A.E.; Luque-Ramirez, M.; Escobar-Morreale, H.F. Síndrome de ovário poliquistico en la mujer adulta. Medicina Clínica. Vol. 152. Num.11. 2019. p.450-457.
-Romanowski, M.D; Parolin, M.B.; Freitas, A.C.T; Piazza, M.J.; Basso, J.; Urbanetz, A.A. Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome. Arquivos de Gastroenterologia. Vol. 52. Num. 2. 2015. p. 117-123.
-Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. Vol. 81. Num. 1. 2004. p. 19-25.
-Santos, T.S.; Batista, A.S.; Brandão, I.M.; Carvalho, F.L.O.C.; Martins, F.L.; Costa, D.M.; Barassa, C.A.R.; Junior, L.R.G. Aspectos Nutricionais e Manejo Alimentar em Mulheres Com Síndrome dos Ovários Policísticos. Revista Saúde em Foco. Vol. 11. 2019. p. 649-670.
-Sayyah-Melli, M.; Alizadeh, M.; Pourafkary, N..; Ouladsahebmadarek, E.; Jafari-Shobeiri, M.; Abbassi, J.; Kazemi-Shishvan, M. A.; Sedaghat, K. Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study. Journal of Caring Sciences. Vol. 4. Num. 3. 2015. p. 225-231.
-Spritzer, P.M. Diagnóstico etiológico do hirsutismo e implicações para o tratamento. Revista Brasileira de Ginecologia e Obstetrícia. Vol. 31. Num. 1. 2009. p. 41-47.
-Sousa, R.M.L.; Chein, M.B.C.; Silva, D.S.M.; Dutra, M.B.; Navarro, P.A.A.S.; Neto, J.A.F.; Brito, L.M.O. Perfil metabólico em mulheres de diferentes índices de massa corporal com síndrome dos ovários policísticos. Revista Brasileira de Ginecologia e Obstetrícia. Vol. 35. Num. 9. 2013. p. 413-420.
-Studen, K.B.; Pfeifer, M. Cardimetabolic risk in polycystic ovary syndrome. Endocrine Connections. Vol. 7. Num. 7. 2018. p. 238-251.
-Valentim, G.F.S.; Monteiro, P.I.P.; Silveira, A.L.R.; Valentim, A.L.S.; Marinho. R.M. Prevalência de distúrbios metabólicos em pacientes portadores de síndrome dos ovários policísticos atendidas no ambulatório da CMMG. Revista Interdisciplinar Ciências Médicas. Vol. 3. Num. 2. 2019. p. 30-35.
-Wang, Q.Y.; Song, Y.; Huang, W.; Xiao, L.; Wang, Q.S.; Feng, G.M. Comparison of drospirenone-with cyproterone acetate-containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders. Chinese Medical Journal. Vol. 129. Num. 8. 2016. p. 883-890.
-WHO. World Health Organization. Physical status: the use and interpretation of anthropometry. Genebra, 1995. 452p. (Technical Report Series No. 854).
Copyright (c) 2022 Patrícia Cassiano Campos, Fernanda Faciroli, Yara Fernanda Alves Andrade, Marcio Leandro Ribeiro de Souza
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).
